Clinical Trials Browser

Phase 1/2 × Completed × cabazitaxel × Clear all

NCT01751308 2016-08-12

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Phase 1/2 Completed

39 enrolled 18 charts

Other solid neoplasm

Malignant Solid Tumor - Malignant Nervous System Neoplasm